Use of gold nanoshells to mediate heating induced perfusion changes in prostate tumors

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 6842, Issue , 2008, Pages

  Shetty, Anil ^a   Elliott, Andrew M ^a   Schwartz, Jon A ^b   Wang, James ^b   Esparza Coss, Emilio ^a   Klumpp, Sherry ^a   Taylor, Brian ^a   Hazle, John D ^a   Stafford, R Jason ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Nanospectra Biosciences Inc   (United States)

Author keywords

Contrast uptake; Gold nanoshells; MR temperature imaging; Prostate cancer; Tumor perfusion

Indexed keywords

ABSORPTION; CHEMOTHERAPY; DRUG DELIVERY; DRUG DOSAGE; DRUG THERAPY; GOLD; HEATING; MAGNETIC FIELDS; MAGNETISM; MODULATION; NANOSTRUCTURED MATERIALS; ONCOLOGY; OPTICS; RADIATION; RADIATION EFFECTS; RESONANCE; TISSUE; TUMORS;

ABLATIVE THERAPY; DYNAMIC CONTRAST; GOLD NANOSHELLS; MAGNETIC (CE); NANOSHELL; NANOSHELLS; NEAR INFRA-RED (NIR); PHOTONIC; PROSTATE TUMORS; REAL TIME; RESONANCE TEMPERATURE; SHUT DOWN; TEMPERATURE RISE; TUMOR PERFUSION; TUMOR VASCULATURE; VASCULATURE;

NANOSTRUCTURES;

EID: 42149108657     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.763160     Document Type: Conference Paper

References (40)

1. Jemal, A., et al., Cancer statistics, 2007. CA Cancer J Clin, 2007. 57(1): p. 43-66.
2. Jemal, A., et al., Cancer statistics, 2006. CA Cancer J Clin, 2006. 56(2): p. 106-30.
3. Klimberg, I., et al., Early prostate cancer: is there a need for new treatment options? Urol Oncol, 2003. 21(2): p. 105-16.
4. Jain, R.K., Molecular regulation of vessel maturation. Nat Med, 2003. 9(6): p. 685-93.
5. Bott, S.R., et al., Prostate cancer management: 2. An update on locally advanced and metastatic disease. Postgrad Med J, 2003. 79(937): p. 643-5.
6. Wasson, J., et al., The treatment of localized prostate cancer: what are we doing, what do we know, and what should we be doing? The Prostate Patient Outcome Research Team. Semin Urol, 1993. 11(1): p. 23-6.
7. Roos, N.P., et al., Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med, 1989. 320(17): p. 1120-4.
8. Chen, Q. and F.W. Hetzel, Laser dosimetry studies in the prostate. J Clin Laser Med Surg, 1998. 16(1): p. 9-12.
9. Eggener, S.E., et al., Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol, 2007. 178(6): p. 2260-7.
10. Merrick, G.S., et al., Initial analysis of Pro-Qura: a multi-institutional database of prostate brachytherapy dosimetry. Brachytherapy, 2007. 6(1): p. 9-15.
11. Huang, W.C., et al., The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies. J Urol, 2007. 177(4): p. 1324-9; quiz 1591.
12. Servadio, C., Z. Leib, and A. Lev, Diseases of prostate treated by local microwave hyperthermia. Urology, 1987. 30(2): p. 97-9.
13. Hazle, J.D., et al., MRI-guided thermal therapy of transplanted tumors in the canine prostate using a directional transurethral ultrasound applicator. J Magn Reson Imaging, 2002. 15(4): p. 409-17.
14. Johannsen, M., et al., Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model. Prostate, 2005. 64(3): p. 283-92.
15. O'Neal, D.P., R.J. Stafford, and J.D. Hazle, Magnetic resonance temperature imaging of nanoshell photothermal therapy. Proceedings of SPIE ~ Volume 6095 Nanobiophotonics and Biomedical Applications III, 2006.
16. Monsky, W.L., et al., Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Res, 1999. 59(16): p. 4129-35.
17. Kong, G., et al., Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res, 2000. 60(24): p. 6950-7.
18. Hosono, M.N., et al., Effect of hyperthermia on tumor uptake of radiolabeled anti-neural cell adhesion molecule antibody in small-cell lung cancer xenografts. J Nucl Med, 1994. 35(3): p. 504-9.
19. Fujiwara, K. and T. Watanabe, Effects of hyperthermia, radiotherapy and thermoradiotherapy on tumor microvascular permeability. Acta Pathol Jpn, 1990. 40(2): p. 79-84.
20. Gaber, M.H., et al., Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. Int J Radiat Oncol Biol Phys, 1996. 36(5): p. 1177-87.
21. Meyer, D.E., et al., Drug targeting using thermally responsive polymers and local hyperthermia. J Control Release, 2001. 74(1-3): p. 213-24.
22. Kong, G., R.D. Braun, and M.W. Dewhirst, Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res, 2001. 61(7): p. 3027-32.
23. De Poorter, J., et al., Noninvasive MRI thermometry with the proton resonance frequency (PRF) method: in vivo results in human muscle. Magn Reson Med, 1995. 33(1): p. 74-81.
24. Sherar, M.D., et al., Comparison of thermal damage calculated using magnetic resonance thermometry, with magnetic resonance imaging post-treatment and histology, after interstitial microwave thermal therapy of rabbit brain. Phys Med Biol, 2000. 45(12): p. 3563-76.
25. Ishihara, Y., et al., A precise and fast temperature mapping using water proton chemical shift. Magn Reson Med, 1995. 34(6): p. 814-23.
26. Hindman, J., Proton Resonance Shift of Water in the Gas and Liquid States. The Journal of Chemical Physics, 1966. 44(12): p. 4582-4592.
27. Carmeliet, P. and R.K. Jain, Angiogenesis in cancer and other diseases. Nature, 2000. 407(6801): p. 249-57.
28. Cao, Y., et al., Impact of hypoxia and hypercapnia on calcium oxalate toxicity in renal epithelial and interstitial cells. Urol Res, 2006. 34(4): p. 271-6.
29. Liu, P., et al., Study of non-uniform nanoparticle liposome extravasation in tumour. Int J Hyperthermia, 2005. 21(3): p. 259-70.
30. Yuh, W.T., An exciting and challenging role for the advanced contrast MR imaging. J Magn Reson Imaging, 1999. 10(3): p. 221-2.
31. Padhani, A.R., Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging, 2002. 16(4): p. 407-22.
32. Hylton, N., Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol, 2006. 24(20): p. 3293-8.
33. Checkley, D., et al, Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours. Br J Cancer, 2003. 89(10): p. 1889-95.
34. Gray, L.H., et al., The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol, 1953. 26(312): p. 638-48.
35. Dean, M., T. Fojo, and S. Bates, Tumour stem cells and drug resistance. Nat Rev Cancer, 2005. 5(4): p. 275-84.
36. Minchinton, A.I. and I.F. Tannock, Drug penetration in solid tumours. Nat Rev Cancer, 2006. 6(8): p. 583-92.
37. Oldenberg, S.J. and e. al;, Infrared extinction properties of gold nanoshells. Applied Physics Letters, 1999. 75(19): p. p. 2897-2899.
38. Duff, D., A New Hydrosol of Gold Clusters. 1. Formation and Particle Size Variation. Langmuir, 1993(9): p. 2301-2309.
39. Padhani, A.R. and J.E. Husband, Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. Clin Radiol, 2001. 56(8): p. 607-20.
40. Mayr, N. A., et al., Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay. Int J Radiat Oncol Biol Phys, 1996. 36(3): p. 623-33.